Comparative solution equilibrium studies of antitumor ruthenium(η6-p-cymene) and rhodium (η5-C5Me5) complexes of 8-hydroxyquinolines

被引:47
作者
Domotor, Orsolya [1 ,2 ]
Pape, Veronika F. S. [3 ]
May, Nora V. [4 ]
Szakacs, Gergely [3 ,5 ]
Enyedy, Eva A. [1 ]
机构
[1] Univ Szeged, Dept Inorgan & Analyt Chem, Dom Ter 7, H-6720 Szeged, Hungary
[2] Univ Szeged, MTA SZTE Bioinorgan Chem Res Grp, Dom Ter 7, H-6720 Szeged, Hungary
[3] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary
[4] Hungarian Acad Sci, Res Ctr Nat Sci, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary
[5] Med Univ Vienna, Inst Canc Res, Borschkegasse 8a, A-1090 Vienna, Austria
关键词
PENTAMETHYLCYCLOPENTADIENYL-RHODIUM; ANTICANCER AGENTS; ORGANOMETALLIC CHEMISTRY; IRIDIUM(III) COMPLEXES; MULTIDRUG-RESISTANCE; ARENE COMPLEXES; RUTHENIUM; CANCER; GALLIUM(III); IMPACT;
D O I
10.1039/c7dt00439g
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Complex formation processes of [Ru(eta(6)-p-cymene)(H2O)(3)](+) and [Rh(eta(5)-C5Me5)(H2O)(3)](+) organometallic cations with 8-hydroxyquinoline (HQ) ligands were studied in aqueous solution by the combined use of H-1 NMR spectroscopy, UV-visible spectrophotometry and pH-potentiometry. Solution stability, chloride ion affinity and lipophilicity of the complexes were characterized together with the in vitro cytotoxicity against a pair of cancer cell lines, responsive and resistant to classic chemotherapy. The solid phase structure of the [Rh(eta(5)-C5Me5)(8-quinolinolato)(Cl)] complex was characterized by single-crystal X-ray diffraction analysis. In addition to the unsubstituted HQ its 7-(1-piperidinylmethyl) (PHQ) and 5-sulfonate (HQS) derivatives were involved. PHQ has a significant preference for targeting multidrug resistant cancer cell lines, while HQS served as a water soluble model compound. The equilibrium studies revealed the formation of mono[M(L)(H2O)] complexes with prominently high solution stability, which predominate at physiological pH even in the micromolar concentration range, and the formation of mixed hydroxido [M(L)(OH)] complexes was characterized by relatively high pKa values (8.5-10.3). In comparison to the Rh(eta(5)-C5Me5) species the complexation process with Ru(eta(6)-p-cymene) is much slower, and both the pKa values and the H2O/Cl- co-ligand exchange constants are lower by 1-1.5 orders of magnitude. The stability order obtained for these organometallic complexes is as follows: HQS > HQ > PHQ. The cytotoxicity of the ligands and their Ru(eta(6)-p-cymene) and Rh(eta(5)-C5Me5) complexes was investigated against MES-SA (human uterine sarcoma) cell line and its multidrug resistant counterpart (MES-SA/Dx5). HQ and its complexes show similar cytotoxicity in both cell lines. In contrast, PHQ and its Rh(eta(5)-C5Me5) complex are more potent against MES-SA/Dx5 cells, while this selectivity could not be observed for the Ru(eta(6)-p-cymene) complex.
引用
收藏
页码:4382 / 4396
页数:15
相关论文
共 61 条
[1]   Ruthenium antimetastatic agents [J].
Alessio, E ;
Mestroni, G ;
Bergamo, A ;
Sava, G .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (15) :1525-1535
[2]   Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective [J].
Alessio, Enzo .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2017, (12) :1549-1560
[3]   8-hydroxyquinoline monomer, water adducts, and dimer.: Environmental influences on structure, spectroscopic properties, and relative stability of cis and trans conformers [J].
Amati, Mario ;
Belviso, Sandra ;
Cristinziano, Pier Luigi ;
Minichino, Camilla ;
Lelj, Francesco ;
Aiello, Iolinda ;
La Deda, Massimo ;
Ghedini, Mauro .
JOURNAL OF PHYSICAL CHEMISTRY A, 2007, 111 (51) :13403-13414
[4]   Organometallic ruthenium-based antitumor compounds with novel modes of action [J].
Ang, Wee Han ;
Casini, Angela ;
Sava, Gianni ;
Dyson, Paul J. .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2011, 696 (05) :989-998
[5]  
[Anonymous], 2013, SHELXL 2013 PROGR CR
[6]  
[Anonymous], 2008, CRYSTALCLEAR SM 1 4
[7]   Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study [J].
Biro, Linda ;
Farkas, Etelka ;
Buglyo, Peter .
DALTON TRANSACTIONS, 2012, 41 (01) :285-291
[8]   CONTROLLING PLATINUM, RUTHENIUM, AND OSMIUM REACTIVITY FOR ANTICANCER DRUG DESIGN [J].
Bruijnincx, Pieter C. A. ;
Sadler, Peter J. .
ADVANCES IN INORGANIC CHEMISTRY, VOL 61: METAL ION CONTROLLED REACTIVITY, 2009, 61 :1-62
[9]   The Contrasting Chemistry and Cancer Cell Cytotoxicity of Bipyridine and Bipyridinediol Ruthenium(II) Arene Complexes [J].
Bugarcic, Tijana ;
Habtemariam, Abraha ;
Stepankova, Jana ;
Heringova, Pavla ;
Kasparkova, Jana ;
Deeth, Robert J. ;
Johnstone, Russell D. L. ;
Prescimone, Alessandro ;
Parkin, Andrew ;
Parsons, Simon ;
Brabec, Viktor ;
Sadler, Peter J. .
INORGANIC CHEMISTRY, 2008, 47 (24) :11470-11486
[10]   Novel half-sandwich Ru(II)-hydroxamate complexes: synthesis, characterization and equilibrium study in aqueous solution [J].
Buglyo, Peter ;
Farkas, Etelka .
DALTON TRANSACTIONS, 2009, (38) :8063-8070